These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27355571)

  • 1. p21 governs p53's repressive side.
    Fischer M
    Cell Cycle; 2016 Nov; 15(21):2852-2853. PubMed ID: 27355571
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.
    Fischer M; Uxa S; Stanko C; Magin TM; Engeland K
    Sci Rep; 2017 Jun; 7(1):2603. PubMed ID: 28572607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein.
    Singh M; Mukhopadhyay T
    Mol Cell Biochem; 2018 Jun; 443(1-2):101-110. PubMed ID: 29147811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.
    Tarapore P; Horn HF; Tokuyama Y; Fukasawa K
    Oncogene; 2001 May; 20(25):3173-84. PubMed ID: 11423967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
    Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
    Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer biology: The dark side of p21.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2016 Aug; 17(8):461. PubMed ID: 27381242
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers.
    Shiraishi T; Watanabe M; Muneyuki T; Nakayama T; Morita J; Ito H; Kotake T; Yatani R
    Urol Int; 1998; 61(2):90-4. PubMed ID: 9873247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus.
    Hanas JS; Lerner MR; Lightfoot SA; Raczkowski C; Kastens DJ; Brackett DJ; Postier RG
    Cancer; 1999 Sep; 86(5):756-63. PubMed ID: 10463972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic side of p53's oncosuppressive activities.
    Comel A; Sorrentino G; Capaci V; Del Sal G
    FEBS Lett; 2014 Aug; 588(16):2600-9. PubMed ID: 24747877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a differential modulation of p53-phosphorylating kinases by the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
    Neise D; Sohn D; Budach W; Jänicke RU
    Cell Cycle; 2010 Sep; 9(17):3575-83. PubMed ID: 20818156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
    Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
    Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression.
    Kallassy M; Martel N; Damour O; Yamasaki H; Nakazawa H
    Mol Carcinog; 1998 Jan; 21(1):26-36. PubMed ID: 9473769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status.
    Agarwal S; Mathur M; Shukla NK; Ralhan R
    Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
    Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
    Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.